Provided by Tiger Fintech (Singapore) Pte. Ltd.

Ritter Pharmaceuticals

0.4480
0.0000
Volume:- -
Turnover:- -
Market Cap:20.68M
PE:-1.03
High:0.4480
Open:0.4480
Low:0.4480
Close:0.4480
Loading ...

Company Profile

Company Name:
Ritter Pharmaceuticals
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Ritter Pharmaceuticals, Inc. develops and sells therapeutic products that modulate the gut microbiome to treat digestive disorders and gastrointestinal diseases. Its lead product candidate is RP-G28, an orally administered galacto-oligosaccharide that is in Phase III clinical trials for the treatment of lactose intolerance. The company was formerly known as Ritter Natural Sciences, LLC and changed its name to Ritter Pharmaceuticals, Inc. in September 2008. Ritter Pharmaceuticals, Inc. was founded in 2004 and is headquartered in Los Angeles, California.